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Abstract
Background: Steroid-resistant nephrotic syndrome (SRNS) is associated with early atherosclerosis because of comorbidities in-
cluding persistent hyperlipidemia and hypertension. The aim of this study was to determine the incidence of abnormal carotid
intima-media thickening (cIMT) as an early sign of atherosclerosis in a small group of children with SRNS.
Methods: A total of 8 children with SRNS (mean age, 10.8±4.2 years at recruitment and mean disease duration, 40.9± 20.7 months)
were studied; all children were normotensive. B-mode ultrasound was used to measure cIMT, and the results were compared with
healthy controls.
Results: Children with SRNS had significantly thicker CIMT (0.44±0.04 mm), compared to the controls (0.37±0.59 mm) (P < 0.01).
A high level of total cholesterol (5.4± 2.0 mmol/L; normal < 5.2 mmol/L) was reported in these children, while normal levels of low-
density lipoprotein, very-low-density lipoprotein, triglyceride, and high-density lipoprotein were found. Also, the mean creatinine
level was 45.1± 15.0µmol/L, and the mean urea level was 4.2± 1.8 mmol/L.
Conclusions: Children with SRNS had an abnormal vascular phenotype with a thicker CIMT, compared to the controls and showed
evidence of hypercholesterolemia.
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1. Background
Nephrotic syndrome is associated with an atherogenic
lipoprotein profile of increased total plasma cholesterol
and low-density lipoprotein (LDL) (1, 2). Children with
steroid-resistant nephrotic syndrome (SRNS) are chroni-
cally exposed to abnormal lipid levels. Also, high serum
lipid level in adults is an established risk factor for
atherosclerosis (3), cardiovascular diseases (CVDs), and
even cardiac death (4).
Adult patients with SRNS have been shown to experi-
ence more than a 5-fold increase in the relative risk of my-
ocardial infarction (MI), as well as a significant rise in the
relative risk of coronary death within 5.6 years of follow-up
(4). The increased risks may be partly attributed to hyper-
lipidemia, although hypoalbuminemia and hypercoagula-
ble state may be also involved (5).
In adults, risk of CVD can be partly related to tradi-
tional risk factors (TRFs), such as advanced age, obesity,
and cigarette smoking. These risk factors are not normally
present in children with SRNS. However, there are some re-
ports of cardiovascular events in these children. In this re-
gard, Silva et al. reported a case of acute MI in a 7-year-old
boy with SRNS (6), and Hopp et al. reported MI in another
7-year-old boy, who had been diagnosed with SRNS 5 years
before ischemic heart disease (7).
Assessment of common carotid artery intima-media
thickness (A-cIMT) is a relatively reliable and simple mea-
sure. In the atherosclerosis risk in communities (ARIC)
study, CCA-IMT was compared with all carotid artery seg-
ments (A-cIMT), complemented with TRFs and plaque in-
formation, in terms of coronary heart disease risk predic-
tion.
With this background in mind, in this pilot study,
we aimed to determine the incidence of abnormal
carotid intima-media thickening (cIMT) as an early sign of
atherosclerosis in a small group of children with SRNS.
2. Methods
We recruited children with primary SRNS who met the
following inclusion criteria: (1) age above 5 years; (2) diag-
nosis of SRNS at least 3 months prior to the study; and (3) re-
nal biopsy with defined underlying histopathology. On the
other hand, we excluded children with stage 2 (or above)
chronic kidney disease (CKD), as defined by the estimated
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glomerular filtration rate (eGFR) below 90 mL/min/1.73 M2.
Written consents were obtained from the parents.
In all recruited children, cIMT was measured, and
blood tests were performed to determine renal function
(creatinine and urea levels), serum albumin level, urine
albumin/creatinine ratio, lipid profile, C-reactive protein,
and complete blood count. The blood samples were rou-
tinely processed at the laboratory of great ormond street
hospital for children NHS foundation trust.
The body mass index (BMI)-for-age growth chart by the
centre for disease control and prevention was used to cal-
culate BMI percentiles (www.cdc.gov). Detailed family his-
tory was evaluated in terms of cardiovascular events (be-
fore 55 years in males and before 65 years in females), using
the expert panel on integrated guidelines for Cardiovascu-
lar health and risk reduction. The Schwartz formula was
also used to measure eGFR (8).
2.1. Measurement of cIMT
B-mode ultrasound was used to measure cIMT of both
common carotid arteries, using a 12-MHz linear-array
transducer and a single ultrasound machine (Vivid7, GE
healthcare, Horton, Norway). A 15-heartbeat cine-loop
recording was obtained for the oﬄine analysis, using the
Digital Imaging and Communications in Medicine soft-
ware. The mean IMT of a segment (0.5 - 1 cm) was mea-
sured 1 cm proximal to the carotid bifurcation, using an
automated edge detection system on 2 separate images of
the right and left common carotid arteries (from true end-
diastolic frames), as determined by the minimum vessel di-
ameter. Approximately 120 individual measurements were
performed across the artery (1-cm length). The measure-
ments were repeated in 3 different cardiac cycles, and the
average of 3 measurements from the right and left arteries
was recorded.
2.2. Statistical Analysis
Mean ± standard deviation (SD) was calculated for
normally distributed data, and the median (range) was
used for the rest of the data. Unpaired 2-tailed t test
was used to compare the mean values. Statistical analy-
ses were performed, using GraphPad Prism version 6.0b
for Mac OS X (GraphPad Software, La Jolla, California, USA;
www.graphpad.com). P value less than 0.05 was consid-
ered statistically significant.
In this study, ethical approval was obtained from the
Institute of child health of the university college London
and the research ethics committee of Great Ormond Street
hospital for children NHS foundation trust.
3. Results
A total of 8 children with SRNS were recruited in this
study, 5 of whom were female. The mean age of the subjects
was 6.9± 5.3 years at presentation and 10.8± 4.2 years at
recruitment. Also, the mean disease duration was 40.9±
20.7 months (Table 1). Overall, 4 children were identified as
Caucasian, 2 as Indian, and 2 as Pakistani. All children had
normal blood pressure (mean systolic blood pressure, 103
± 7 mmHg; mean diastolic blood pressure, 63± 6 mmHg).
Also, the mean BMI was 21.8± 4.0 g/m2.
Table 1. Demographic Characteristics and Vascular Phenotypes in Children with
SRNS and the Controls
Characteristics SRNS Control P Value
Age, y 10.8± 4.2 13.2± 4.8
Gender (F:M) 5:3 19:20
Age at presentation, y 6.9± 5.3
Disease duration,mo 40.9± 20.7
CIMT,mm 0.44± 0.04 0.37± 0.59 0.0016
Carotid-femoral PWV,m/s (n =
5)
5.06± 0.76 5.34± 0.97 0.5498
Carotid-radial PWV,m/s (n = 9) 6.97± 1.79
Abbreviations: CIMT, carotid intima-media thickness; PWV, pulse wave velocity.
Renal biopsy showed focal segmental glomeruloscle-
rosis in 4 cases, minimal change of disease in 2 cases, and
membranoproliferative glomerulonephritis in 2 cases. A
total of 40 age-matched children were recruited as the con-
trols (9). Table 1 outlines the demographic characteristics
of patients and controls. Based on the findings, the mean
creatinine level was 45.1 ± 15.0 µmol/L, the mean blood
urea level was 4.2 ± 1.8 mmol/L, and the mean eGFR was
120.9± 22.9 mL/min/1.73 M2; it should be noted that we ex-
cluded children with GFR < 90 mL/min/1.73 M2. All children
showed normal CRP, white blood cell count, hemoglobin
level, and platelet count.
The analysis of lipid profile showed a mean choles-
terol level of 5.4 ± 2.0 mmol/L (normal < 5.2 mmol/L),
triglyceride level of 1.74 ± 0.64 mmol/L (normal, 0.45 -
1.71 mmol/L), LDL level of 3.1 ± 2.1 mmol/L (normal < 3.4
mmol/L), very-low-density lipoprotein (VLDL) level of 0.79
± 0.29 mmol/L (normal, 0.128 - 0.645 mmol/L), and high-
density lipoprotein (HDL) level of 1.2 ± 0.3 mmol/L (nor-
mal, 0.8 - 1.8 mmol/L).
During the study, 6 children were in the remission
stage with a serum albumin level of > 35 gm/L, while the re-
maining patients (n = 2) had active disease. Only 4 children
had normal urine albumin/creatinine ratio (< 30 mg/g),
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while the remaining patients had significant or nephrotic-
range proteinuria with the median of 35.2 (range, 1.8 - 1080)
in the whole group.
3.1. cIMT
The mean cIMT was 0.44± 0.04 mm for children with
SRNS and 0.37± 0.06 mm for the controls (Figure 1). Chil-
dren with SRNS showed a significant increase in cIMT, com-
pared to the controls (0.07 mm; P = 0.0016). However, the
values were too small to permit comparison between his-












Figure 1. cIMT in Children with SRNS and the Controls
4. Discussion
In the present study, we found evidence of early
changes in the structure of blood vessels in children with
SRNS, as they had thicker CIMT, compared to the controls.
This finding is similar to the results reported by Hooman et
al. who demonstrated increased cIMT in children with id-
iopathic nephrotic syndrome (both steroid-sensitive and -
resistant), associated with the duration of disease and hy-
pertension (10).
Furthermore, Candan et al. reported changes in cIMT,
pulse wave velocity, and left ventricular mass in children
with SRNS, which were significantly correlated with pro-
teinuria (11), leading to cardiovascular complications. The
main reason is probably multifactorial, including the as-
sociated hyperlipidemia (12), hypertension, tendency to
thrombosis (13, 14), and use of immunosuppressive med-
ications. SRNS is also associated with increased endothe-
lial markers, such as soluble thrombomodulin, plasmino-
gen activator inhibitor-1, tissue plasminogen activator, and
von-Willebrand factor (15), all of which are related to en-
dothelial activation.
Despite achieving remission in the majority of cases
during the present research, the study group had an
atherogenic lipid profile with high cholesterol level. Nev-
ertheless, the effect of long exposure to disease could per-
sist even after remission, as shown in previous studies (10).
We excluded children with stage 2 CKD (or above) in order
to avoid the confounding effect of impaired renal function
in the cardiovascular system (16).
Overall, use of lipid-lowering agents in children with
SRNS is limited, and only few reports are available (17).
However, given the reported association between in-
creased VLDL level and subclinical CVD in children with
SRNS (10), such treatments could be indicated; in fact,
more comprehensive studies are required in this area.
4.1. Conclusions
Children with SRNS showed enhanced cIMT, thus indi-
cating the increased risk of CVD.
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